Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
Clinical trial NCT04416126 · COMPLETED
Trial details
- NCT number
- NCT04416126
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-12-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.